• mv-slider
  • lazy: true
HOME
サブ-ナビゲーション
  • information
  • News
  • Corporate Guide
  • Business
  • Investor Relations
  • Sustainability
  • Contact Us

HOME

NEWS

  • What’s new
  • Press Release
  • Investor Relations
  • Information
  • 2026/04/27 Notice Regarding Cancellation of Treasury Stock pdf （250KB）
  • 2026/04/27 Notice about Share Consolidation, Abolition of the Provision on Share Units and Partial Amendment of the Articles of Incorporation pdf （536KB）
  • 2026/04/07 Announcement of Results of the Tender Offer by Takara Holdings, the Parent Company of the Company, for the Common Stock of the Company pdf （348KB）
  • 2026/03/26 Notice Regarding Setting of Record Date for Convocation of Extraordinary General Shareholders’ Meeting pdf （194KB）
  • 2026/02/13 (Summary) Notice Concerning Expression of Opinion in Support of Tender Offer for Company Shares by Takara Holdings, and Recommendation to Tender Share pdf （254KB）
  • Read More
  • 2026/02/06 Waskyra™, a Gene Therapy Manufactured Using RetroNectin®, Receives U.S. and EU Marketing Authorization Approvals
  • 2025/09/16 Completion of Clinical Trial Notification Process in Japan for Confirmatory Study of NY-ESO-1・siTCR™ Gene Therapy
  • 2025/09/12 Announcement of “Takara Bio Group Long-Term Vision 2050”
  • 2025/06/04 Redesign of the Regulatory Strategy for NY-ESO-1・siTCR™ Gene Therapy in Japan
  • 2024/06/27 Takara Bio announces the business partnership with Gap Junction Therapeutics to develop AAV gene therapy for hereditary hearing loss
  • Read More
  • 2026/04/27 Notice Regarding Cancellation of Treasury Stock pdf （250KB）
  • 2026/04/27 Notice about Share Consolidation, Abolition of the Provision on Share Units and Partial Amendment of the Articles of Incorporation pdf （536KB）
  • 2026/04/07 Announcement of Results of the Tender Offer by Takara Holdings, the Parent Company of the Company, for the Common Stock of the Company pdf （348KB）
  • 2026/03/26 Notice Regarding Setting of Record Date for Convocation of Extraordinary General Shareholders’ Meeting pdf （194KB）
  • 2026/02/13 (Summary) Notice Concerning Expression of Opinion in Support of Tender Offer for Company Shares by Takara Holdings, and Recommendation to Tender Share pdf （254KB）
  • Read More
  • 2024/05/02 Takara Bio to Present Advances in Gene and Cell Research at ASGCT 2024
  • Read More

BUSINESS

  • Read More

Research reagents

Scientific instruments

CDMO

Gene Therapy

INVESTORRELATIONS

  • Read More

SUSTAINABILITY

  • Read More

COMPANY

  • Read More

PAGETOP
PAGETOP
  • CLOSE
  • MENU

サイト内検索

  • footer-content
  • menu
  • JA
  • EN
  • contact
  • gnavi-box